These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31503152)

  • 61. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Influence of age on tolerability, safety and effectiveness of subdermal contraceptive implants.
    López Del Cerro E; Serrano Diana C; Castillo Cañadas AM; González Mirasol E; García Santos F; Gómez García MT; González de Merlo G
    J Obstet Gynaecol; 2018 Oct; 38(7):979-984. PubMed ID: 29553853
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
    Weisberg E; Merki-Feld GS; McGeechan K; Fraser IS
    Contraception; 2015 Feb; 91(2):121-6. PubMed ID: 25459098
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association of body mass index with removal of etonogestrel subdermal implant.
    Casey PM; Long ME; Marnach ML; Fleming-Harvey J; Drozdowicz LB; Weaver AL
    Contraception; 2013 Mar; 87(3):370-4. PubMed ID: 22959901
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment of rectovaginal endometriosis with the etonogestrel-releasing contraceptive implant.
    Ferrero S; Scala C; Ciccarelli S; Vellone VG; Barra F
    Gynecol Endocrinol; 2020 Jun; 36(6):540-544. PubMed ID: 31711348
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Etonogestrel Implant in Adolescents: Factors Associated With Removal for Bothersome Bleeding in the First Year After Insertion.
    Green S; Sheeder J; Richards M
    J Pediatr Adolesc Gynecol; 2021 Dec; 34(6):825-831. PubMed ID: 34089858
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 20 microg versus >20 microg estrogen combined oral contraceptives for contraception.
    Gallo MF; Nanda K; Grimes DA; Lopez LM; Schulz KF
    Cochrane Database Syst Rev; 2008 Oct; (4):CD003989. PubMed ID: 18843653
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 20 µg versus >20 µg estrogen combined oral contraceptives for contraception.
    Gallo MF; Nanda K; Grimes DA; Lopez LM; Schulz KF
    Cochrane Database Syst Rev; 2011 Jan; (1):CD003989. PubMed ID: 21249657
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects.
    Laurikka-Routti M; Haukkamaa M
    Fertil Steril; 1992 Dec; 58(6):1142-7. PubMed ID: 1459263
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immediate postpartum etonogestrel implant: a contraception option with long-term continuation.
    Wilson S; Tennant C; Sammel MD; Schreiber C
    Contraception; 2014 Sep; 90(3):259-64. PubMed ID: 24993485
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effects of Implanon on menstrual bleeding patterns.
    Mansour D; Korver T; Marintcheva-Petrova M; Fraser IS
    Eur J Contracept Reprod Health Care; 2008 Jun; 13 Suppl 1():13-28. PubMed ID: 18330814
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel.
    Funk S; Miller MM; Mishell DR; Archer DF; Poindexter A; Schmidt J; Zampaglione E;
    Contraception; 2005 May; 71(5):319-26. PubMed ID: 15854630
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of Etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis: Results from a prospective, observational study.
    Niu X; Luo Q; Wang C; Zhu L; Huang L
    Medicine (Baltimore); 2021 Feb; 100(6):e24597. PubMed ID: 33578561
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Multicenter trial of two monophasic oral contraceptives containing 30 mcg ethinylestradiol and either desogestrel or gestodene in Thai women.
    Koetsawang S; Charoenvisal C; Banharnsupawat L; Singhakovin S; Kaewsuk O; Punnahitanont S
    Contraception; 1995 Apr; 51(4):225-9. PubMed ID: 7796587
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Etonogestrel implant as a contraceptive choice; patient acceptability and adverse effect profile in a general practice setting.
    Riney S; O'Shea B; Forde A
    Ir Med J; 2009 Jan; 102(1):24-5. PubMed ID: 19284015
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Etonogestrel implant in postpartum adolescents: bleeding pattern, efficacy and discontinuation rate.
    Guazzelli CA; de Queiroz FT; Barbieri M; Torloni MR; de Araujo FF
    Contraception; 2010 Sep; 82(3):256-9. PubMed ID: 20705154
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Release characteristics, ovarian activity and menstrual bleeding pattern with a single contraceptive implant releasing 3-ketodesogestrel.
    Davies GC; Feng LX; Newton JR; Van Beek A; Coelingh-Bennink HJ
    Contraception; 1993 Mar; 47(3):251-61. PubMed ID: 8462316
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A clinical evaluation of bleeding patterns, adverse effects, and satisfaction with the subdermal etonogestrel implant among postpartum and non-postpartum users.
    Wahab NA; Rahman NA; Mustafa KB; Awang M; Sidek AA; Ros RM
    Int J Gynaecol Obstet; 2016 Feb; 132(2):237-8. PubMed ID: 26617248
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.